Stuart Gibb, Ph.D.

For over 20 years I’ve worked across startups, mid-sized biotechs, and global CGT device manufacturers — I’ve been in the trenches, built the teams, and now help both Biotechs and Investors assemble the right tools to accelerate their cell therapy ambitions.

My scientific foundation began with a Ph.D. in Molecular Biology from the University of Cambridge, where I engineered viral vector systems to explore how we can intervene in disease at its most fundamental level. That early work ignited a lifelong commitment to translating complex science into real-world therapies.

Over the years, I’ve built a career at the intersection of science, manufacturing, and business development — tackling the challenges of cell therapy manufacturing, GMP-grade bioreactors, and commercialization. I’ve helped bridge the gap between breakthrough innovation and scalable, patient-focused solutions.

Today, as Founder of Labyrinth CGT Consulting, LLC, I partner with early-stage biotech teams and investors to close critical gaps, stay lean, and maximize value creation — providing strategic messaging, manufacturing guidance, and objective scientific and market analysis to turn vision into execution and product commercialization.

— Stuart Gibb, Ph.D.